Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuqiguben Paste (Fuqi Guben Gao) is a traditional Chinese medicine (TCM) formulation developed by the Yunnan Institute of Materia Medica. It is primarily indicated for the treatment of kidney yang deficiency syndrome, a condition in TCM characterized by symptoms such as fatigue, cold extremities, and lower back soreness. The formulation is designed to tonify kidney yang and strengthen the body's foundation (Guben). Fuqiguben Paste has undergone Phase 1 clinical evaluation in China (CTR20180871) to assess its safety, tolerability, and pharmacokinetics in healthy volunteers. As a TCM paste, it is typically applied topically or percutaneously, utilizing a complex mixture of herbal extracts to achieve its therapeutic effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuqiguben Paste.